{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:55:43Z","timestamp":1790888143217,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjcard.2026.09.025","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:30:27Z","timestamp":1790749827000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions \u2013 Results from SOLOIST-WHF"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-5371","authenticated-orcid":false,"given":"Zugui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarahfaye","family":"Dolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.amjcard.2026.09.025_bib0001","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.amjcard.2026.09.025_bib0002","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjcard.2026.09.025_bib0003","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/heartjnl-2022-321097","article-title":"Management of patients with heart failure and preserved ejection fraction","volume":"109","author":"Jasinska-Piadlo","year":"2023","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.amjcard.2026.09.025_bib0004","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart Failure With Reduced Ejection Fraction: A Review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0005","series-title":"StatPearls. Treasure Island (FL) with ineligible companies. Disclosure: Pirbhat Shams declares no relevant financial relationships with ineligible companies","article-title":"Heart Failure With Preserved Ejection Fraction (HFpEF)","author":"Golla","year":"2024"},{"issue":"2","key":"10.1016\/j.amjcard.2026.09.025_bib0006","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amjcard.2026.09.025_bib0007","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jchf.2024.04.018","article-title":"Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF","volume":"12","author":"Weintraub","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.amjcard.2026.09.025_bib0008","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7326\/M21-0651","article-title":"Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial","volume":"174","author":"Szarek","year":"2021","journal-title":"Ann Intern Med"},{"issue":"8 Pt 1","key":"10.1016\/j.amjcard.2026.09.025_bib0009","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jchf.2023.05.026","article-title":"Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF","volume":"11","author":"Pitt","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1016\/j.amjcard.2026.09.025_bib0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jacc.2023.02.022","article-title":"Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure","volume":"81","author":"Verma","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0012","first-page":"14","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statitical Assoc"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0013","unstructured":"Federal Supply Schedule: Drugs, Pharmaceuticals, & Hematology Related Products. U.S. Department of Veterans Affairs. (https:\/\/www.va.gov\/opal\/nac\/fss\/pharmaceuticals.asp)."},{"key":"10.1016\/j.amjcard.2026.09.025_bib0014","unstructured":"(HCUP) HCaUP. Introduction to the HCUP National Inpatient Sample (NIS). Agency for Healthcare Research and Quality."},{"issue":"20","key":"10.1016\/j.amjcard.2026.09.025_bib0015","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to Methodological Standards in Research Using the National Inpatient Sample","volume":"318","author":"Khera","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0016","unstructured":"National Health Expenditure Data: Historical. Centers for Medicare & Medicaid Services. (https:\/\/www.cms.gov\/data-research\/statistics-trends-and-reports\/national-health-expenditure-data)."},{"issue":"10","key":"10.1016\/j.amjcard.2026.09.025_bib0017","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health Care Spending in the United States and Other High-Income Countries","volume":"319","author":"Papanicolas","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0018","unstructured":"Per Capita Personal Healthcare Costs in the US in 2020, by Gender and Age Group. Statista. (https:\/\/www.statista.com\/statistics\/1478769\/per-capita-personal-healthcare-costs-us-by-gender)."},{"issue":"5","key":"10.1016\/j.amjcard.2026.09.025_bib0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1377\/hlthaff.2013.1224","article-title":"US health spending trends by age and gender: selected years 2002-10","volume":"33","author":"Lassman","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0020","unstructured":"Luciani MTR. Comparing two measures of core inflation: PCE excluding food and energy vs. the trimmed mean PCE index. Board of Governors of the Federal Reserve System. (https:\/\/www.federalreserve.gov\/econres\/notes\/feds-notes\/comparing-two-measures-of-core-inflation-20190802.html)."},{"issue":"1","key":"10.1016\/j.amjcard.2026.09.025_bib0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1475-6773.12612","article-title":"Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States","volume":"53","author":"Dunn","year":"2018","journal-title":"Health Serv Res"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0022","unstructured":"Personal Consumption Expenditures (PCE) Price Index. Bureau of Economic Analysis. (https:\/\/www.bea.gov\/data\/personal-consumption-expenditures-price-index)."},{"issue":"7","key":"10.1016\/j.amjcard.2026.09.025_bib0023","first-page":"1","article-title":"United States Life Tables, 2017","volume":"68","author":"Arias","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"10","key":"10.1016\/j.amjcard.2026.09.025_bib0024","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"10440","key":"10.1016\/j.amjcard.2026.09.025_bib0025","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amjcard.2026.09.025_bib0026","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12955-020-01407-y","article-title":"Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review","volume":"18","author":"Betts","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12913-015-0772-9","article-title":"Acute and chronic impact of cardiovascular events on health state utilities","volume":"15","author":"Matza","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0028","series-title":"Operations research and health care","first-page":"593","article-title":"Modeling medical treatment using Markov decision processes","author":"AJ","year":"2005"},{"issue":"10","key":"10.1016\/j.amjcard.2026.09.025_bib0029","first-page":"1124","article-title":"Multi-model Markov decision processes","volume":"53","author":"Steimle","year":"2021","journal-title":"IISE Transactions"},{"key":"10.1016\/j.amjcard.2026.09.025_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/CEOR.S135445","article-title":"Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review","volume":"9","author":"Olariu","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"issue":"8","key":"10.1016\/j.amjcard.2026.09.025_bib0031","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamacardio.2021.1437","article-title":"Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction","volume":"6","author":"Parizo","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10.1016\/j.amjcard.2026.09.025_bib0032","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamainternmed.2022.5010","article-title":"Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction","volume":"182","author":"Zheng","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"16","key":"10.1016\/j.amjcard.2026.09.025_bib0033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjcard.2026.09.025_bib0034","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2023.0077","article-title":"Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction","volume":"8","author":"Cohen","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926006016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926006016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:02:19Z","timestamp":1790884939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926006016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0002914926006016"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.09.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions \u2013 Results from SOLOIST-WHF","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}